Would you have Chest Pain when you have Multiple Sclerosis?

Summary

Chest pain is found among people with Multiple sclerosis, especially for people who are female, 40-49 old, take medication Avonex and have Multiple sclerosis. We study 4,075 people who have Chest pain and Multiple sclerosis from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone

Join a support group for people who have Multiple sclerosis and Chest pain >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Multiple Sclerosis

Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) can be treated by Copaxone, Avonex, Tysabri, Rebif, Baclofen (latest reports from 215,630 Multiple sclerosis patients)

Chest Pain

Chest pain has been reported by people with hypotension, pain, weakness, fatigue, stress and anxiety (latest reports from 133,750 Chest pain patients).

On Jul, 18, 2016

4,075 people who have Multiple Sclerosis and Chest Pain are studied.


Number of reports submitted per year:

Would you have Chest pain when you have Multiple sclerosis?

Gender of people who have Multiple Sclerosis and experience Chest Pain *:

  • female: 80.67 %
  • male: 19.33 %

Age of people who have Multiple Sclerosis and experience Chest Pain *:

  • 0-1: 0.03 %
  • 2-9: 0.0 %
  • 10-19: 0.69 %
  • 20-29: 6.77 %
  • 30-39: 17.51 %
  • 40-49: 31.46 %
  • 50-59: 31.14 %
  • 60+: 12.41 %

Severity if Multiple Sclerosis and experience Chest Pain *:

  • least: 0.0 %
  • moderate: 66.67 %
  • severe: 33.33 %
  • most severe: 0.0 %

Top co-existing conditions for these people *:

  • Multiple Sclerosis (4,073 people)
  • Hypertension (97 people)
  • Depression (83 people)
  • Pain (70 people)
  • Muscle Spasms (41 people)
  • Fatigue (35 people)
  • Gastrooesophageal Reflux Disease (34 people)
  • Insomnia (31 people)
  • Blood Cholesterol Increased (30 people)
  • Anxiety (29 people)

Most common drugs for these people *:

  • Avonex (1,376 people)
  • Tysabri (1,251 people)
  • Rebif (591 people)
  • Gilenya (457 people)
  • Copaxone (319 people)
  • Baclofen (249 people)
  • Betaseron (181 people)
  • Neurontin (179 people)
  • Provigil (115 people)
  • Aspirin (112 people)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Chest pain and Multiple sclerosis?

Browse all symptoms of Multiple sclerosis

a b c d e f g h i j k l m n o p q r s t u v w x y z

Could your drugs cause Chest pain

Chest pain

Other conditions that could case Chest pain

Chest pain

Can you answer these questions?

More questions for: Multiple sclerosis, Chest pain

You may be interested in these reviews

More reviews for: Multiple sclerosis, Chest pain


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.